Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReneuron Regulatory News (RENE)

  • This share is currently suspended. It was suspended at a price of 3.275

Share Price Information for Reneuron (RENE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.275
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3.275
RENE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

4 Feb 2022 17:17

RNS Number : 8003A
ReNeuron Group plc
04 February 2022
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

ReNeuron Group PLC

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

Obotritia Capital KGaA

City and country of registered office (if applicable)

Potsdam, Germany

4. Full name of shareholder(s) (if different from 3.)v

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

02/02/2022

6. Date on which issuer notified (DD/MM/YYYY):

03/02/2022

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

9.71%

-

9.71%

57,063,623

Position of previous notification (if

applicable)

10.76%

-

10.76%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB00BF5G6K95

5,539,386

9.71%

SUBTOTAL 8. A

5,539,386

9.71%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

X

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional informationxvi

 

Place of completion

Potsdam, Germany

Date of completion

03/02/2022

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLEAXALEFLAEFA
Date   Source Headline
9th Oct 20069:50 amRNSTo Present Data in October
21st Sep 200611:49 amRNSRe: Warrant Holder Meeting
21st Sep 200611:45 amRNSAGM Statement
19th Sep 20063:39 pmRNSIssue of Equity
4th Sep 20065:31 pmRNSDirector/PDMR Shareholding
4th Sep 20065:31 pmRNSDirector/PDMR Shareholding
4th Sep 20065:23 pmRNSDirector/PDMR Shareholding
4th Sep 20065:18 pmRNSDirector/PDMR Shareholding
30th Aug 200612:03 pmRNSHolding(s) in Company
30th Aug 200611:57 amRNSHolding(s) in Company
23rd Aug 20063:19 pmRNSAGM
23rd Aug 20067:01 amRNSRe: Clinical Investigator
29th Jun 20062:21 pmRNSHolding(s) in Company
29th Jun 20067:02 amRNSResearch Update
28th Jun 20067:01 amRNSRe Placing
28th Jun 20067:01 amRNSFinal Results
26th Jun 20063:27 pmRNSNotice of Results
5th Jun 20067:02 amRNSConference
11th May 20062:35 pmRNSHolding(s) in Company
26th Apr 20065:17 pmRNSDirector/PDMR Shareholding
26th Apr 20065:13 pmRNSDirector/PDMR Shareholding
26th Apr 20065:09 pmRNSDirector/PDMR Shareholding
26th Apr 20065:03 pmRNSDirector/PDMR Shareholding
26th Apr 20064:59 pmRNSDirector/PDMR Shareholding
18th Apr 20067:02 amRNSRe Agreement
18th Apr 20067:02 amRNSRe Agreement
10th Apr 20061:52 pmRNSHolding(s) in Company
5th Apr 20069:08 amRNSIntention to raise funds
4th Apr 20069:52 amRNSResearch Update
8th Mar 20067:32 amRNSResearch Update
7th Mar 20067:00 amRNSRe: BioSquare Conference
16th Feb 20067:01 amRNSResearch Update
7th Feb 20067:01 amRNSRe: Manufacturing Contract
6th Feb 20067:01 amRNSResearch Update
24th Jan 20067:00 amRNSRe US Patent Office
6th Dec 200510:03 amRNSRe Conference
2nd Dec 200511:19 amRNSRe: Government Support
30th Nov 20057:00 amRNSInterim Results
23rd Nov 20054:57 pmRNSNotice of Results
18th Nov 20057:00 amRNSResearch Update
25th Oct 20057:00 amRNSResearch Update
5th Oct 20059:59 amRNSHolding(s) in Company
22nd Sep 200510:31 amRNSResearch Update
20th Sep 20059:13 amRNSDirector/PDMR Shareholding
16th Sep 20051:08 pmRNSDirector/PDMR Shareholding
16th Sep 20051:06 pmRNSDirector/PDMR Shareholding
16th Sep 20051:05 pmRNSDirector/PDMR Shareholding
16th Sep 20051:03 pmRNSDirector/PDMR Shareholding
16th Sep 20051:01 pmRNSDirector/PDMR Shareholding
12th Aug 20057:00 amRNSAdmission to Trading on AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.